Compare LGND & ASTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LGND | ASTH |
|---|---|---|
| Founded | 1987 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 1.2B |
| IPO Year | 1992 | N/A |
| Metric | LGND | ASTH |
|---|---|---|
| Price | $187.63 | $25.33 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 9 |
| Target Price | ★ $239.33 | $41.33 |
| AVG Volume (30 Days) | 203.6K | ★ 534.7K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 0.76 | N/A |
| EPS | ★ 2.49 | 0.20 |
| Revenue | $251,233,000.00 | ★ $2,896,452,000.00 |
| Revenue This Year | $52.87 | $58.46 |
| Revenue Next Year | $6.07 | $25.59 |
| P/E Ratio | ★ $76.34 | $129.09 |
| Revenue Growth | 64.83 | ★ 68.17 |
| 52 Week Low | $93.58 | $20.12 |
| 52 Week High | $212.49 | $39.97 |
| Indicator | LGND | ASTH |
|---|---|---|
| Relative Strength Index (RSI) | 41.53 | 57.89 |
| Support Level | $194.44 | $24.47 |
| Resistance Level | $198.80 | $25.54 |
| Average True Range (ATR) | 5.54 | 0.88 |
| MACD | -0.55 | 0.39 |
| Stochastic Oscillator | 33.30 | 92.84 |
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.